secwatch.observer — SEC 8-K summary
======================================

Issuer:     CODEXIS, INC. (CDXS)
CIK:        0001200375
Form:       8-K
Filed at:   2026-03-11T23:59:59+00:00
Accession:  0001193125-26-102146
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Codexis Q4 revenue jumps 81% to $38.9M, net income of $9.6M; FY2025 revenue up 19%
--------------------------------------------------------------------------------

- Q4 2025 revenue of $38.9M (up 81% YoY); net income $9.6M vs net loss of $10.4M in Q4 2024.
- FY2025 total revenue $70.4M (+19% YoY); product gross margin improved to 64% from 56%.
- FY2025 net loss narrowed to $44.0M ($0.50 per share) from $65.3M ($0.89 per share) in FY2024.
- Cash and investments $78.2M; management expects cash runway through 2027.
- Introduced FY2026 revenue guidance of $72M-$76M; highlights include $37.8M Merck tech transfer deal and multiple partnerships.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1200375/000119312526102146/0001193125-26-102146-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1200375/000119312526102146/d106216d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-102146

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer